Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). - sprookjes - yvandenbroek - TriplyDB

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

http://www.wikidata.org/entity/Q33978927

about

Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus Treatment of gastric cancer Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?Neoadjuvant therapy for gastric cancer: current evidence and future directions Minimally Invasive Versus Open Total Gastrectomy for Gastric Cancer: A Systematic Review and Meta-analysis of Short-Term Outcomes and Completeness of Resection : Surgical Techniques in Gastric Cancer Neoadjuvant or adjuvant therapy for gastric cancer Gastric cancer review Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series.Clinicopathological correlation and prognostic significance of sonic hedgehog protein overexpression in human gastric cancer Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancer Capecitabine in gastric cancer.Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.Medical management of gastric cancer: a 2014 update.Adjuvant therapy for gastric cancer: current and future directions.Multimodality management of resectable gastric cancer: A review.Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Gastric cancer: current status of diagnosis and treatment High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis.Chemotherapy for operable gastric cancer: current perspectives Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296).Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.DNA and histone methylation in gastric carcinogenesis Adjuvant treatment for gastric cancer: chemotherapy versus radiation The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas Targeted therapy in gastric cancer.Gastric cancer-molecular and clinical dimensions.Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.Randomized trials and quality assurance in gastric cancer surgery.Quality of care indicators for the surgical treatment of gastric cancer: a systematic review.Adjuvant therapy in gastric cancer: what is the optimal approach?Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

P2860

Q24202957-D251C042-9CB8-4D04-B960-7F9F539F40D8 Q24602875-78555153-E798-4E2E-BFB9-D494F15B3568 Q26774283-915FAF90-4EE0-4607-949C-1EED55902160 Q26774533-780B5B94-5294-4D76-8AA1-4D9EFEA64C33 Q26781043-054D1C1D-10C4-4262-BA84-118FFA3AB9E0 Q26782547-C7DC0696-07A0-44C7-A7B9-232CD3081D67 Q26797427-C8A75BE8-21B8-4D9D-8FA2-CCDAF87EA763 Q27025793-89CFD37E-F5AF-4E97-B938-841CF1723A77 Q28086772-644CBE77-0BD9-463E-A788-746B744B7397 Q28088619-94981E2F-47C1-4AD7-A841-704B4EB12B96 Q30872867-5E0100B6-2346-4639-9410-7B8A04A584B2 Q31150068-13B395F2-EEF6-4BF3-901B-1F702FF4931B Q33650849-5C19A276-241A-4090-8A76-6F115BA93BD1 Q34121564-064F35DD-1F14-4E24-8596-ECB9139985E1 Q34160552-083C7F08-60F6-4BB3-B526-7A388FC9F69E Q34236005-242ABF72-008D-4AA9-84C6-FA2572572DF0 Q34255467-EB2D0F98-6861-47DE-B910-B35139D20082 Q34267378-E9FABFE3-5402-4219-B729-94C7E03FF230 Q34326546-7FB8A009-8E51-41F7-A1C6-904258A1F507 Q34326579-2F1B039A-EBC5-4617-BFDC-36F9DDBB2F2E Q34340956-76726127-0803-42AD-BF00-97C3B9ED924A Q34479911-E4B71B88-13DB-4C4B-83C8-E9DCB0F99A5D Q34657361-76E841F2-96DB-449C-A5EC-463EFDD9BCFA Q34702116-8C35409C-F9D4-4D21-BEDE-E59020DBA214 Q35737764-B2829D16-0DBC-4BAA-88E9-A51B4801E0C4 Q35917089-DF1711F0-1F57-45DC-938F-890BFE0DD327 Q36373630-3A01FBEC-6F61-4550-B336-CA65A278555D Q36401587-12B46026-D478-4609-9198-C79ED8A4BC4D Q36498930-62007BB2-CC25-48A8-8524-9A6A089772BF Q36567393-758E1B4E-82F6-4EA3-8F59-10BD070E26D3 Q36654458-BF9ACC55-EE20-480B-A71B-03BEBA04F562 Q37191333-D97E63CC-F449-46E5-8B96-7A3258E7F7BA Q37217887-DF628539-7F5E-4467-BD24-E217B7377696 Q37341824-C950CB45-8A91-43B3-A25D-C9387BCDC342 Q37591176-CD7AD53B-8098-4811-A93D-885585C3971C Q37697546-92A71DFA-E266-435C-8FD3-C969C3C303CB Q38001383-A675B702-B561-4BA6-A861-A233FF142EED Q38051100-754611B0-4976-4F83-AF99-0BFC2C5DEE90 Q38077141-9A0673BB-A9F3-4064-B270-5E05397AA095 Q38092435-A3B96AEA-08E2-4FA7-A15A-B855F5DD8454

P2860

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

http://www.wikidata.org/entity/Q33978927

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Neo-adjuvant chemotherapy foll ...... able gastric cancer (CRITICS).

@ast

Neo-adjuvant chemotherapy foll ...... able gastric cancer (CRITICS).

@en

type

label

Neo-adjuvant chemotherapy foll ...... able gastric cancer (CRITICS).

@ast

Neo-adjuvant chemotherapy foll ...... able gastric cancer (CRITICS).

@en

prefLabel

Neo-adjuvant chemotherapy foll ...... able gastric cancer (CRITICS).

@ast

Neo-adjuvant chemotherapy foll ...... able gastric cancer (CRITICS).

@en

P1433

Q33978927-E97A60E1-11CC-418E-900E-2E93FC9A2B26

P1476

Q33978927-FE568311-1C2A-42BB-885C-075F21D6DD49

P2093

Q33978927-1C3F8083-5C13-4801-875A-F4B3AF70340F

Q33978927-50F0CB42-4657-4FF3-8107-73D86E0D841B

Q33978927-683DC74C-19AE-40DF-B4D6-A1B55D18EF49

Q33978927-6B43ECDA-5841-4CA7-A356-CE8D88415E92

Q33978927-7408D270-F54F-4E7A-995A-8D56A868AE9D

Q33978927-A8392340-212C-48B8-9C1D-535BA9771DDD

Q33978927-AB60ECFA-079C-4DBD-904E-6E333A745D54

Q33978927-AE031F14-9C1A-4542-8283-756C117A3944

Q33978927-D1DCDC7B-D3A6-4F68-8A21-FD1C15A7470F

Q33978927-D3B04B43-9814-4822-B672-DB8087779F07

P2860

Q33978927-0745FB73-87CF-491B-9A73-15CC9E87530B

Q33978927-0A360182-D5EC-4D71-9295-B427DE4CF3CB

Q33978927-0A5A9D04-2309-4C2B-8854-D52CAA8BBAB3

Q33978927-0AD120C3-F1FD-42ED-BEE0-4964FA2A0881

Q33978927-0DDB794D-B7B7-4F73-B186-9F7B4ABE975B

Q33978927-12317052-64A2-486F-BE98-A7FF36C3CF7F

Q33978927-15D70BAF-974C-4CED-879C-6040C8DC2503

Q33978927-187ED7F0-5D35-419E-986E-8F0CD788DB3A

Q33978927-1ED53D40-1B92-49EA-8643-FAF57F75FFDD

Q33978927-1F91FFBE-7B61-45D1-8D47-7ADE49643241

P2888

Q33978927-D7024079-F74F-418F-B6AB-A632895BFF3C

P304

Q33978927-9057503E-6EAA-453D-9D60-BD5A4B67EA65

P31

Q33978927-2B77A2E9-B489-42A8-B675-C2712D159949

P356

Q33978927-CF5C1273-0B8C-46EA-9469-D88AAAAB05D4

P407

Q33978927-F24E10E4-774D-4F30-A3AF-57AC03A42DE9

P478

Q33978927-82CAEEE3-132D-402E-A517-4E01687C9D0E

P577

Q33978927-E120ED71-06F6-4897-B0F6-EE43489C4910

P5875

Q33978927-87EA7EA6-9920-4BEE-9EBC-FC47B895909A

P6179

Q33978927-8DF6E27F-25A8-4ECA-A530-E8DDC09EFAB7

P698

Q33978927-EFE06507-A464-488D-A2D2-C4290AF4417B

P921

Q33978927-A2D4D162-C171-4DF4-B4CB-9E0A067DEE4F

Q33978927-B259E4A9-823B-47FC-AA6B-30160924A7FE

P932

Q33978927-A1D946D9-46DB-43D8-AD53-53B1AA10B4EC

P356

1471-2407-11-329

P1433

P1476

Neo-adjuvant chemotherapy foll ...... able gastric cancer (CRITICS).

@en

P2093

Annemieke Cats

http://www.w3.org/2001/XMLSchema#string

Cornelis J H van de Velde

http://www.w3.org/2001/XMLSchema#string

Edwin P M Jansen

http://www.w3.org/2001/XMLSchema#string

H A Maurits Swellengrebel

http://www.w3.org/2001/XMLSchema#string

Hein Putter

http://www.w3.org/2001/XMLSchema#string

Henk Boot

http://www.w3.org/2001/XMLSchema#string

Johan L Dikken

http://www.w3.org/2001/XMLSchema#string

Johanna W van Sandick

http://www.w3.org/2001/XMLSchema#string

Marcel Verheij

http://www.w3.org/2001/XMLSchema#string

Nicole C T van Grieken

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

Gastric cancer--patterns of relapse after surgical resection.

Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

P2888

1471-2407-11-329

P304

329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-329

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51541292

http://www.w3.org/2001/XMLSchema#string

P6179

1039430522

http://www.w3.org/2001/XMLSchema#string

P698

21810227

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3175221

http://www.w3.org/2001/XMLSchema#string